Answers are grounded in this paper and cite their sources.
Randomized trials demonstrate improved survival in men with metastatic prostate cancer, suggesting effective treatment strategies are crucial.
Interventions added to androgen-deprivation therapy in men with metastatic prostate cancer have recently been noted to increase survival. Decisions about which treatments to use and in what order to maximize the benefit should be made on the basis of high-quality clinical trials.
No takes yet. Share an insight, caveat, or question.
Sartor et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: